127 related articles for article (PubMed ID: 18474528)
21. Several nuclear events during apoptosis depend on caspase-3 activation but do not constitute a common pathway.
Trisciuoglio L; Bianchi ME
PLoS One; 2009 Jul; 4(7):e6234. PubMed ID: 19641621
[TBL] [Abstract][Full Text] [Related]
22. HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.
Stros M; Polanská E; Struncová S; Pospísilová S
Nucleic Acids Res; 2009 Apr; 37(7):2070-86. PubMed ID: 19223331
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional regulation: it takes a village.
Panning B; Taatjes DJ
Mol Cell; 2008 Sep; 31(5):622-9. PubMed ID: 18775322
[TBL] [Abstract][Full Text] [Related]
24. Chromatin-associated HMGA and HMGB proteins: versatile co-regulators of DNA-dependent processes.
Grasser KD
Plant Mol Biol; 2003 Oct; 53(3):281-95. PubMed ID: 14750519
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding.
Roemer SC; Adelman J; Churchill ME; Edwards DP
Nucleic Acids Res; 2008 Jun; 36(11):3655-66. PubMed ID: 18474528
[TBL] [Abstract][Full Text] [Related]
26. The role of the C-terminal extension (CTE) of the estrogen receptor alpha and beta DNA binding domain in DNA binding and interaction with HMGB.
Melvin VS; Harrell C; Adelman JS; Kraus WL; Churchill M; Edwards DP
J Biol Chem; 2004 Apr; 279(15):14763-71. PubMed ID: 14739282
[TBL] [Abstract][Full Text] [Related]
27. A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain.
Hill KK; Roemer SC; Jones DN; Churchill ME; Edwards DP
J Biol Chem; 2009 Sep; 284(36):24415-24. PubMed ID: 19553667
[TBL] [Abstract][Full Text] [Related]
28. The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins.
Melvin VS; Roemer SC; Churchill ME; Edwards DP
J Biol Chem; 2002 Jul; 277(28):25115-24. PubMed ID: 12006575
[TBL] [Abstract][Full Text] [Related]
29. Structural and functional analysis of domains of the progesterone receptor.
Hill KK; Roemer SC; Churchill ME; Edwards DP
Mol Cell Endocrinol; 2012 Jan; 348(2):418-29. PubMed ID: 21803119
[TBL] [Abstract][Full Text] [Related]
30. Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements.
Roemer SC; Donham DC; Sherman L; Pon VH; Edwards DP; Churchill ME
Mol Endocrinol; 2006 Dec; 20(12):3042-52. PubMed ID: 16931575
[TBL] [Abstract][Full Text] [Related]
31. Synergistic functions of SII and p300 in productive activator-dependent transcription of chromatin templates.
Guermah M; Palhan VB; Tackett AJ; Chait BT; Roeder RG
Cell; 2006 Apr; 125(2):275-86. PubMed ID: 16630816
[TBL] [Abstract][Full Text] [Related]
32. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor.
Kim MY; Woo EM; Chong YT; Homenko DR; Kraus WL
Mol Endocrinol; 2006 Jul; 20(7):1479-93. PubMed ID: 16497729
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
